B cell Repertoire Recovery Following Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma: Information from Minimal Residual Disease (MRD) Testing

Key Points

• B cell repertoire recovery shows significant improvement post-transplantation, revealing immune system restoration.
• Key evidence indicates that tracking minimal residual disease levels correlates with enhanced recovery outcomes.
• Assessment using minimal residual disease testing provides insights into immune recovery after treatment.
• Findings suggest ongoing monitoring of B cell repertoire could inform patient management and therapy adjustments.